Skip to main content

Klinger Shannon Thyme's Form 4 filing

Moderna, Inc. (MRNA) · filed Aug 31, 2026

Accession no.
0001682852-26-000157
Filed
Aug 31, 2026, 4:37 PM ET
Trade date
Aug 27-28, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Klinger Shannon ThymeCIK 0001866132Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 27, 2026Common StockMOption exerciseAcquired+774––74,335Direct
Aug 27, 2026Common StockFTax withholdingDisposed−375$149.66−$56,122.573,960Direct
Aug 28, 2026Common StockMOption exerciseAcquired+329––74,289Direct
Aug 28, 2026Common StockFTax withholdingDisposed−160$142.77−$22,843.274,129Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 27, 2026Common StockMOption exerciseDisposed−774$0.00$04,642Direct
Aug 28, 2026Common StockMOption exerciseDisposed−329$0.00$0658Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)